Dr. Heiko Singer

Dr. Heiko Singer is a seasoned professional in the field of medical affairs, currently serving as the Medical Affairs Team Lead and Medical Advisor at Oncopeptides AB since June 2021. Previously, Dr. Singer held various roles, including Therapy Area Medical Lead at Incyte from September 2019 to May 2021, Regional Medical Liaison at Celgene from May 2016 to July 2019, and Medical Manager New Products as well as Medical Advisor at Novartis between December 2010 and May 2016. Additionally, Dr. Singer worked as a Clinical Research Manager in a freelance capacity from September 2009 to November 2010. Dr. Singer obtained a Doctor of Philosophy (PhD) in Genetics from FAU Erlangen-Nürnberg.